Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and gemcitabine in progressive regional or metastatic bladder cancer and related transitional cell cancer…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Bladder Cancer [Phase 3]
A Phase 3 clinical trial update on combination chemotherapy for bladder cancer and urethral cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) [Phase 2]
Phase 2 trial DUTRENEO evaluating durvalumab and tremelimumab as neoadjuvant therapy in bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) [Phase 3]
Phase 3 trial update investigating fluorescence cystoscopy and optimized mitomycin C for recurrent bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Clinical trial update for VPM1002BC in recurrent non-muscle invasive bladder cancer across Phase 1 and Phase 2, status completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Single-Dose Intravesical Chemotherapy After Diagnostic URS [Phase 3]
Phase 3 trial investigating single-dose intravesical chemotherapy following diagnostic ureteroscopy for upper urinary tract urothelial carci…
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB) [Phase 2]
Phase 2 clinical trial evaluating antimicrobial prophylaxis in patients undergoing transurethral resection of the bladder (TURB).
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
Phase 2 single-arm study of bempegaldesleukin (NKTR-214) with nivolumab in cisplatin-ineligible, locally advanced or metastatic urothelial c…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC [Phase 2]
Phase 2 clinical trial update evaluating radiation plus durvalumab as neoadjuvant therapy for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: En-bloc vs Conventional Resection of Primary Bladder Tumor [Phase 3]
Phase 3 clinical trial comparing en-bloc versus conventional resection of primary bladder tumor has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]
A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma [Phase 4]
A Phase 4 clinical trial is evaluating disitamab vedotin in combination with gemcitabine as neoadjuvant therapy for urothelial carcinoma und…
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine [Phase 1, Phase 2]
Clinical trial update on Catumaxomab for non-muscle-invasive bladder cancer in patients who failed or are intolerant to BCG, spanning Phase …
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of GEN1044 (DuoBody-CD3x5T4) in malignant solid tumors has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of neoadjuvant intravesical mitomycin-C instillation in bladder cancer.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab [Phase 2]
A Phase 2 neoadjuvant trial assessing pembrolizumab monotherapy in muscle-invasive bladder cancer to study mechanisms of action.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer [Phase 2]
Phase 2 trial update evaluating response to two induction courses (12 intravesical instillations) of BCG for high-risk superficial bladder c…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating tremelimumab and IV durvalumab with Poly-ICLC in biopsy-accessible cancers; completed with results posted in 2022…
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) [Phase 2]
Phase 2 trial evaluating IPI-549 in combination with nivolumab for advanced urothelial carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 clinical trial update for Everolimus (RAD001) in metastatic transitional cell carcinoma of the urothelium (bladder cancer) completed…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC [Phase 2]
A Phase 2 trial compared neoadjuvant chemotherapy to surgery alone in patients with high-grade upper tract urothelial carcinoma, completed.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU) [Phase 2]
Phase 2 BAYOU trial evaluating durvalumab alone and in combination with olaparib for advanced platinum-ineligible bladder cancer; results we…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer [Phase 2]
Phase 2 trial evaluating atezolizumab given concurrently with radiotherapy in patients with muscle-invasive bladder cancer.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer [Phase 1]
Phase 1 trial update evaluating pembrolizumab in combination with intravesical BCG solution for recurrent non-muscle-invasive bladder cancer…
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Tranexamic Acid During Cystectomy Trial (TACT) [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating tranexamic acid during cystectomy for bladder cancer.